Salzer Electronics Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 20, 2025, 8:25 pm

Competitors of Salzer Electronics Ltd

All Competitor Stocks of Salzer Electronics Ltd

Quarterly Result

Last Updated: August 20, 2025, 4:10 am

Below is a detailed analysis of the quarterly data for Salzer Electronics Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 432.00 Cr.. The value appears strong and on an upward trend. It has increased from 366.00 Cr. (Mar 2025) to 432.00 Cr., marking an increase of 66.00 Cr..
• For Expenses, as of Jun 2025, the value is 391.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 339.00 Cr. (Mar 2025) to 391.00 Cr., marking an increase of 52.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 41.00 Cr.. The value appears strong and on an upward trend. It has increased from 26.00 Cr. (Mar 2025) to 41.00 Cr., marking an increase of 15.00 Cr..
• For OPM %, as of Jun 2025, the value is 10.00%. The value appears strong and on an upward trend. It has increased from 7.00% (Mar 2025) to 10.00%, marking an increase of 3.00%.
• For Other Income, as of Jun 2025, the value is 1.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2.00 Cr. (Mar 2025) to 1.00 Cr., marking a decrease of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 12.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11.00 Cr. (Mar 2025) to 12.00 Cr., marking an increase of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 24.00 Cr.. The value appears strong and on an upward trend. It has increased from 12.00 Cr. (Mar 2025) to 24.00 Cr., marking an increase of 12.00 Cr..
• For Tax %, as of Jun 2025, the value is 27.00%. The value appears to be improving (decreasing) as expected. It has decreased from 29.00% (Mar 2025) to 27.00%, marking a decrease of 2.00%.
• For Net Profit, as of Jun 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 18.00 Cr., marking an increase of 10.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 9.95. The value appears strong and on an upward trend. It has increased from 4.65 (Mar 2025) to 9.95, marking an increase of 5.30.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: November 15, 2025, 4:31 am

Growth

Last Updated: September 5, 2025, 1:20 pm

Balance Sheet

Last Updated: November 9, 2025, 2:52 pm

Below is a detailed analysis of the balance sheet data for Salzer Electronics Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 18.00 Cr..
• For Reserves, as of Sep 2025, the value is 539.00 Cr.. The value appears strong and on an upward trend. It has increased from 513.00 Cr. (Mar 2025) to 539.00 Cr., marking an increase of 26.00 Cr..
• For Borrowings, as of Sep 2025, the value is 477.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 418.00 Cr. (Mar 2025) to 477.00 Cr., marking an increase of 59.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 278.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 217.00 Cr. (Mar 2025) to 278.00 Cr., marking an increase of 61.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 1,312.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,165.00 Cr. (Mar 2025) to 1,312.00 Cr., marking an increase of 147.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 309.00 Cr.. The value appears strong and on an upward trend. It has increased from 295.00 Cr. (Mar 2025) to 309.00 Cr., marking an increase of 14.00 Cr..
• For CWIP, as of Sep 2025, the value is 6.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2025) to 6.00 Cr., marking an increase of 3.00 Cr..
• For Investments, as of Sep 2025, the value is 28.00 Cr.. The value appears strong and on an upward trend. It has increased from 26.00 Cr. (Mar 2025) to 28.00 Cr., marking an increase of 2.00 Cr..
• For Other Assets, as of Sep 2025, the value is 970.00 Cr.. The value appears strong and on an upward trend. It has increased from 841.00 Cr. (Mar 2025) to 970.00 Cr., marking an increase of 129.00 Cr..
• For Total Assets, as of Sep 2025, the value is 1,312.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,165.00 Cr. (Mar 2025) to 1,312.00 Cr., marking an increase of 147.00 Cr..

Notably, the Reserves (539.00 Cr.) exceed the Borrowings (477.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Salzer Electronics Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 29.75. This value is within the healthy range. It has increased from 27.38 (Mar 24) to 29.75, marking an increase of 2.37.
• For Diluted EPS (Rs.), as of Mar 25, the value is 29.67. This value is within the healthy range. It has increased from 25.94 (Mar 24) to 29.67, marking an increase of 3.73.
• For Cash EPS (Rs.), as of Mar 25, the value is 42.92. This value is within the healthy range. It has increased from 38.65 (Mar 24) to 42.92, marking an increase of 4.27.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 307.62. It has increased from 272.38 (Mar 24) to 307.62, marking an increase of 35.24.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 307.62. It has increased from 272.38 (Mar 24) to 307.62, marking an increase of 35.24.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 802.10. It has increased from 670.96 (Mar 24) to 802.10, marking an increase of 131.14.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 78.74. This value is within the healthy range. It has increased from 68.42 (Mar 24) to 78.74, marking an increase of 10.32.
• For PBIT / Share (Rs.), as of Mar 25, the value is 65.50. This value is within the healthy range. It has increased from 56.85 (Mar 24) to 65.50, marking an increase of 8.65.
• For PBT / Share (Rs.), as of Mar 25, the value is 42.23. This value is within the healthy range. It has increased from 37.24 (Mar 24) to 42.23, marking an increase of 4.99.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 29.68. This value is within the healthy range. It has increased from 27.08 (Mar 24) to 29.68, marking an increase of 2.60.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 28.75. This value is within the healthy range. It has increased from 26.39 (Mar 24) to 28.75, marking an increase of 2.36.
• For PBDIT Margin (%), as of Mar 25, the value is 9.81. This value is below the healthy minimum of 10. It has decreased from 10.19 (Mar 24) to 9.81, marking a decrease of 0.38.
• For PBIT Margin (%), as of Mar 25, the value is 8.16. This value is below the healthy minimum of 10. It has decreased from 8.47 (Mar 24) to 8.16, marking a decrease of 0.31.
• For PBT Margin (%), as of Mar 25, the value is 5.26. This value is below the healthy minimum of 10. It has decreased from 5.54 (Mar 24) to 5.26, marking a decrease of 0.28.
• For Net Profit Margin (%), as of Mar 25, the value is 3.70. This value is below the healthy minimum of 5. It has decreased from 4.03 (Mar 24) to 3.70, marking a decrease of 0.33.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.58. This value is below the healthy minimum of 8. It has decreased from 3.93 (Mar 24) to 3.58, marking a decrease of 0.35.
• For Return on Networth / Equity (%), as of Mar 25, the value is 9.34. This value is below the healthy minimum of 15. It has decreased from 9.68 (Mar 24) to 9.34, marking a decrease of 0.34.
• For Return on Capital Employeed (%), as of Mar 25, the value is 19.11. This value is within the healthy range. It has increased from 18.89 (Mar 24) to 19.11, marking an increase of 0.22.
• For Return On Assets (%), as of Mar 25, the value is 4.30. This value is below the healthy minimum of 5. It has decreased from 4.61 (Mar 24) to 4.30, marking a decrease of 0.31.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.04. This value is below the healthy minimum of 0.2. It has increased from 0.02 (Mar 24) to 0.04, marking an increase of 0.02.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.76. This value is within the healthy range. It has increased from 0.65 (Mar 24) to 0.76, marking an increase of 0.11.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.31. It has increased from 1.24 (Mar 24) to 1.31, marking an increase of 0.07.
• For Current Ratio (X), as of Mar 25, the value is 1.47. This value is below the healthy minimum of 1.5. It has decreased from 1.50 (Mar 24) to 1.47, marking a decrease of 0.03.
• For Quick Ratio (X), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 1. It has decreased from 0.87 (Mar 24) to 0.83, marking a decrease of 0.04.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.29. This value is within the healthy range. It has increased from 3.13 (Mar 24) to 4.29, marking an increase of 1.16.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 8.69. This value is below the healthy minimum of 20. It has increased from 8.00 (Mar 24) to 8.69, marking an increase of 0.69.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 5.95. This value is below the healthy minimum of 20. It has increased from 5.56 (Mar 24) to 5.95, marking an increase of 0.39.
• For Earning Retention Ratio (%), as of Mar 25, the value is 91.31. This value exceeds the healthy maximum of 70. It has decreased from 92.00 (Mar 24) to 91.31, marking a decrease of 0.69.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 94.05. This value exceeds the healthy maximum of 70. It has decreased from 94.44 (Mar 24) to 94.05, marking a decrease of 0.39.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.38. This value is within the healthy range. It has decreased from 3.49 (Mar 24) to 3.38, marking a decrease of 0.11.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.28. This value is below the healthy minimum of 3. It has decreased from 2.38 (Mar 24) to 2.28, marking a decrease of 0.10.
• For Enterprise Value (Cr.), as of Mar 25, the value is 2,319.58. It has increased from 1,759.93 (Mar 24) to 2,319.58, marking an increase of 559.65.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.64. This value is within the healthy range. It has increased from 1.51 (Mar 24) to 1.64, marking an increase of 0.13.
• For EV / EBITDA (X), as of Mar 25, the value is 16.66. This value exceeds the healthy maximum of 15. It has increased from 14.80 (Mar 24) to 16.66, marking an increase of 1.86.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.34. This value is within the healthy range. It has increased from 1.25 (Mar 24) to 1.34, marking an increase of 0.09.
• For Retention Ratios (%), as of Mar 25, the value is 91.30. This value exceeds the healthy maximum of 70. It has decreased from 91.99 (Mar 24) to 91.30, marking a decrease of 0.69.
• For Price / BV (X), as of Mar 25, the value is 3.50. This value exceeds the healthy maximum of 3. It has increased from 3.08 (Mar 24) to 3.50, marking an increase of 0.42.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.34. This value is within the healthy range. It has increased from 1.25 (Mar 24) to 1.34, marking an increase of 0.09.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness